Forskolin Market by Concentration and Application - Global Industry Analysis & Forecast to 2027

Table of Contents:

1.       Introduction

1.1.     Report Description

2.       Executive Summary

2.1.     Key Highlights

3.       Market Overview

3.1.     Introduction

3.1.1.  Market Definition

3.1.2.  Market Segmentation

3.2.     Market Dynamics

3.2.1.  Drivers

3.2.2.  Restraints

3.2.3.  Opportunities

3.3.     SWOT Analysis

4.       Market Analysis by Regions

4.1.     North America (United States, Canada and Mexico)

4.1.1.  United States Market Status and Outlook (2017-2027)

4.1.2.  Canada Market Status and Outlook (2017-2027)

4.1.3.  Mexico Market Status and Outlook (2017-2027)

4.2.     Europe (Germany, France, UK, Russia, Italy and Rest of Europe)

4.2.1.  Germany Market Status and Outlook (2017-2027)

4.2.2.  France Market Status and Outlook (2017-2027)

4.2.3.  UK Market Status and Outlook (2017-2027)

4.2.4.  Russia Market Status and Outlook (2017-2027)

4.2.5.  Italy Market Status and Outlook (2017-2027)

4.2.6.  Rest of Europe Market Status and Outlook (2017-2027)

4.3.     Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)

4.3.1.  China Market Status and Outlook (2017-2027)

4.3.2.  Japan Market Status and Outlook (2017-2027)

4.3.3.  Korea Market Status and Outlook (2017-2027)

4.3.4.  India Market Status and Outlook (2017-2027)

4.3.5.  Southeast Asia Market Status and Outlook (2017-2027)

4.3.6.  Rest of Asia-Pacific Market Status and Outlook (2017-2027)

4.4.     South America (Brazil, Argentina, Columbia and Rest of South America)

4.4.1.  Brazil Market Status and Outlook (2017-2027)

4.4.2.  Argentina Market Status and Outlook (2017-2027)

4.4.3.  Columbia Market Status and Outlook (2017-2027)

4.4.4.  Rest of South America Market Status and Outlook (2017-2027)

4.5.     Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)

4.5.1.  Saudi Arabia Market Status and Outlook (2017-2027)

4.5.2.  United Arab Emirates Market Status and Outlook (2017-2027)

4.5.3.  Egypt Market Status and Outlook (2017-2027)

4.5.4.  Nigeria Market Status and Outlook (2017-2027)

4.5.5.  South Africa Market Status and Outlook (2017-2027)

4.5.6.  Turkey Market Status and Outlook (2017-2027)

4.5.7.  Rest of Middle East and Africa Market Status and Outlook (2017-2027)

5.       Forskolin Market, By Concentration

5.1.     Introduction

5.2.     Global Forskolin Revenue and Market Share by Concentration (2017-2027)

5.2.1.  Global Forskolin Revenue and Revenue Share by Concentration (2017-2027)

5.3.     0.95

5.3.1.  Global 0.95 Revenue and Growth Rate (2017-2027)

5.4.     0.4

5.4.1.  Global 0.4 Revenue and Growth Rate (2017-2027)

5.5.     0.2

5.5.1.  Global 0.2 Revenue and Growth Rate (2017-2027)

5.6.     0.1

5.6.1.  Global 0.1 Revenue and Growth Rate (2017-2027)

6.       Forskolin Market, By Application

6.1.     Introduction

6.2.     Global Forskolin Revenue and Market Share by Application (2017-2027)

6.2.1.  Global Forskolin Revenue and Revenue Share by Application (2017-2027)

6.3.     Insomnia

6.3.1.  Global Insomnia Revenue and Growth Rate (2017-2027)

6.4.     Respiratory Disorders

6.4.1.  Global Respiratory Disorders Revenue and Growth Rate (2017-2027)

6.5.     Weight Management

6.5.1.  Global Weight Management Revenue and Growth Rate (2017-2027)

6.6.     Digestive Disorders

6.6.1.  Global Digestive Disorders Revenue and Growth Rate (2017-2027)

6.7.     Others

6.7.1.  Global Others Revenue and Growth Rate (2017-2027)

7.       Forskolin Market, By Region

7.1.     Introduction

7.2.     Global Forskolin Revenue and Market Share by Regions

7.2.1.  Global Forskolin Revenue by Regions (2017-2027)

7.3.     North America Forskolin by Countries

7.3.1.  North America Forskolin Revenue and Growth Rate (2017-2027)

7.3.2.  North America Forskolin Revenue (Million USD) by Countries (2017-2027)

7.3.3.  United States

7.3.3.1.  United States Forskolin Revenue (Millions USD) and Growth Rate (2017-2027)

7.3.4.  Canada

7.3.4.1.  Canada Forskolin Revenue (Millions USD) and Growth Rate (2017-2027)

7.3.5.  Mexico

7.3.5.1.  Mexico Forskolin Revenue (Millions USD) and Growth Rate (2017-2027)

7.4.     Europe Forskolin by Countries

7.4.1.  Europe Forskolin Revenue and Growth Rate (2017-2027)

7.4.2.  Europe Forskolin Revenue (Million USD) by Countries (2017-2027)

7.4.3.  Germany

7.4.3.1.  Germany Forskolin Revenue (Millions USD) and Growth Rate (2017-2027)

7.4.4.  France

7.4.4.1.  France Forskolin Revenue (Millions USD) and Growth Rate (2017-2027)

7.4.5.  UK

7.4.5.1.  UK Forskolin Revenue (Millions USD) and Growth Rate (2017-2027)

7.4.6.  Russia

7.4.6.1.  Russia Forskolin Revenue (Millions USD) and Growth Rate (2017-2027)

7.4.7.  Italy

7.4.7.1.  Italy Forskolin Revenue (Millions USD) and Growth Rate (2017-2027)

7.4.8.  Rest of Europe

7.4.8.1.  Rest of Europe Forskolin Revenue (Millions USD) and Growth Rate (2017-2027)

7.5.     Asia-Pacific Forskolin by Countries

7.5.1.  Asia-Pacific Forskolin Revenue and Growth Rate (2017-2027)

7.5.2.  Asia-Pacific Forskolin Revenue (Million USD) by Countries (2017-2027)

7.5.3.  China

7.5.3.1.  China Forskolin Revenue (Millions USD) and Growth Rate (2017-2027)

7.5.4.  Japan

7.5.4.1.  Japan Forskolin Revenue (Millions USD) and Growth Rate (2017-2027)

7.5.5.  Korea

7.5.5.1.  Korea Forskolin Revenue (Millions USD) and Growth Rate (2017-2027)

7.5.6.  India

7.5.6.1.  India Forskolin Revenue (Millions USD) and Growth Rate (2017-2027)

7.5.7.  Southeast Asia

7.5.7.1.  Southeast Asia Forskolin Revenue (Millions USD) and Growth Rate (2017-2027)

7.5.8.  Rest of Asia-Pacific

7.5.8.1.  Rest of Asia-Pacific Forskolin Revenue (Millions USD) and Growth Rate (2017-2027)

7.6.     South America Forskolin by Countries

7.6.1.  South America Forskolin Revenue and Growth Rate (2017-2027)

7.6.2.  South America Forskolin Revenue (Million USD) by Countries (2017-2027)

7.6.3.  Brazil

7.6.3.1.  Brazil Forskolin Revenue (Millions USD) and Growth Rate (2017-2027)

7.6.4.  Argentina

7.6.4.1.  Argentina Forskolin Revenue (Millions USD) and Growth Rate (2017-2027)

7.6.5.  Columbia

7.6.5.1.  Columbia Forskolin Revenue (Millions USD) and Growth Rate (2017-2027)

7.6.6.  Rest of South America

7.6.6.1.  Rest of South America Forskolin Revenue (Millions USD) and Growth Rate (2017-2027)

7.7.     Middle East and Africa Forskolin by Countries

7.7.1.  Middle East and Africa Forskolin Revenue and Growth Rate (2017-2027)

7.7.2.  Middle East and Africa Forskolin Revenue (Million USD) by Countries (2017-2027)

7.7.3.  Saudi Arabia

7.7.3.1.  Saudi Arabia Forskolin Revenue (Millions USD) and Growth Rate (2017-2027)

7.7.4.  United Arab Emirates

7.7.4.1.  United Arab Emirates Forskolin Revenue (Millions USD) and Growth Rate (2017-2027)

7.7.5.  Egypt

7.7.5.1.  Egypt Forskolin Revenue (Millions USD) and Growth Rate (2017-2027)

7.7.6.  Nigeria

7.7.6.1.  Nigeria Forskolin Revenue (Millions USD) and Growth Rate (2017-2027)

7.7.7.  South Africa

7.7.7.1.  South Africa Forskolin Revenue (Millions USD) and Growth Rate (2017-2027)

7.7.8.  Turkey

7.7.8.1.  Turkey Forskolin Revenue (Millions USD) and Growth Rate (2017-2027)

7.7.9.  Rest of Middle East and Africa

7.7.9.1.  Rest of Middle East and Africa Forskolin Revenue (Millions USD) and Growth Rate (2017-2027)

8.       Company Profiles

8.1.     Nutra Green Biotechnology Co., Ltd

8.1.1.  Business Overview

8.1.2.   Service Portfolio

8.1.3.  Strategic Developments

8.1.4.  Financial Overview

8.2.     Varion Lifesciences Pvt. Ltd

8.2.1.  Business Overview

8.2.2.   Service Portfolio

8.2.3.  Strategic Developments

8.2.4.  Financial Overview

8.3.     Sabinsa Corporation

8.3.1.  Business Overview

8.3.2.   Service Portfolio

8.3.3.  Strategic Developments

8.3.4.  Financial Overview

8.4.     Bioprex Labs

8.4.1.  Business Overview

8.4.2.   Service Portfolio

8.4.3.  Strategic Developments

8.4.4.  Financial Overview

9.       Global Forskolin Market Competition, by Manufacturer

9.1.     Global Forskolin Financial Overview by Manufacturer (2017-2017)

9.2.     Global Forskolin Price By Region (2017-2017)

9.3.     Top 5 Forskolin Manufacturer Market Share

9.4.     Market Competition Trend

10.    Forskolin Market Forecast (2017-2027)

10.1. Global Forskolin Revenue (Millions USD) and Growth Rate (2017-2027)

10.2. Forskolin Market Forecast by Regions (2017-2027)

10.2.1.      North America Forskolin Market Forecast (2017-2027)

10.2.1.1. United States Forskolin Market Forecast (2017-2027)

10.2.1.2. Canada Forskolin Market Forecast (2017-2027)

10.2.1.3. Mexico Forskolin Market Forecast (2017-2027)

10.2.2.      Europe Forskolin Market Forecast (2017-2027)

10.2.2.1. Germany Forskolin Market Forecast (2017-2027)

10.2.2.2. France Forskolin Market Forecast (2017-2027)

10.2.2.3. UK Forskolin Market Forecast (2017-2027)

10.2.2.4. Russia Forskolin Market Forecast (2017-2027)

10.2.2.5. Italy Forskolin Market Forecast (2017-2027)

10.2.2.6. Rest of Europe Forskolin Market Forecast (2017-2027)

10.2.3.      Asia-Pacific Forskolin Market Forecast (2017-2027)

10.2.3.1. China Forskolin Market Forecast (2017-2027)

10.2.3.2. Japan Forskolin Market Forecast (2017-2027)

10.2.3.3. Korea Forskolin Market Forecast (2017-2027)

10.2.3.4. India Forskolin Market Forecast (2017-2027)

10.2.3.5. Southeast Asia Forskolin Market Forecast (2017-2027)

10.2.3.6. Rest of Asia-Pacific Forskolin Market Forecast (2017-2027)

10.2.4.      South America Forskolin Market Forecast (2017-2027)

10.2.4.1. Brazil Forskolin Market Forecast (2017-2027)

10.2.4.2. Argentina Forskolin Market Forecast (2017-2027)

10.2.4.3. Columbia Forskolin Market Forecast (2017-2027)

10.2.4.4. Rest of South America Forskolin Market Forecast (2017-2027)

10.2.5.      Middle East and Africa Forskolin Market Forecast (2017-2027)

10.2.5.1. Saudi Arabia Forskolin Market Forecast (2017-2027)

10.2.5.2. United Arab Emirates Forskolin Market Forecast (2017-2027)

10.2.5.3. Egypt Forskolin Market Forecast (2017-2027)

10.2.5.4. Nigeria Forskolin Market Forecast (2017-2027)

10.2.5.5. South Africa Forskolin Market Forecast (2017-2027)

10.2.5.6. Turkey Forskolin Market Forecast (2017-2027)

10.2.5.7. Rest of Middle East and Africa Forskolin Market Forecast (2017-2027)

10.3. Forskolin Market Forecast by Concentration (2017-2027)

10.3.1.      Forskolin Forecast by Concentration (2017-2027)

10.3.2.      Forskolin Market Share Forecast by Concentration (2017-2027)

10.4. Forskolin Market Forecast by Application (2017-2027)

10.4.1.      Forskolin Forecast by Application (2017-2027)

10.4.2.      Forskolin Market Share Forecast by Application (2017-2027)

Research Methodology

We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.

Data Mining

Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.

Data Collection Matrix

Market Modeling and Forecasting

We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.

• Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:

• Number of patients for particular device or medical procedure and
• Repeated use of particular device depending on health and condition of patient

• Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.

We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.

Data Validation

We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.

Data Triangulation

Industry Analysis